copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
FDA Clears NMP22 BladderChek for Monitoring of Bladder Cancer NEWTON, Mass Matritech Inc has received clearance from the US Food and Drug Administration to market NMP22 BladderChek for monitoring patients with a history of bladder cancer The test brings rapid detection into the urologist’s office through the use of proteomics technology, the company said in a news release
MATRITECH NMP22(TM) TEST KIT 510(k) FDA Approval Approval for the matritech nmp22 test kit The matritech nmp22 test kit is an enzyme immunoassay (eia) for the in vitro quantitative determination of nuclear matrix protein nmp22 in stabilized voided urine
Matritech’s NMP22® BladderChek™ Test - Bladder Cancer WebCafé Matritech is using its patented proteomics technology to develop diagnostics for the detection of a variety of cancers The Company’s first two products, the NMP22® Test Kit and NMP22® BladderChek® Test, have been approved for the monitoring and diagnosis of bladder cancer
Inverness Medical Innovations Agrees to Acquire Matritech, Inc. Matritech, Inc , a leading marketer and developer of protein-based diagnostic products for the early detection of cancer, is using its patented proteomics technology to develop diagnostics for the detection of a variety of cancers
Inverness Medical Innovations Agrees to Acquire Matritech, Inc. - ThomasNet Matritech, Inc , a leading marketer and developer of protein-based diagnostic products for the early detection of cancer, is using its patented proteomics technology to develop diagnostics for the detection of a variety of cancers
Matritech Inc Company Profile - Dun Bradstreet Find company research, competitor information, contact details financial data for Matritech Inc of Drummondville, QC Get the latest business insights from Dun Bradstreet
The Standard: Matritech, Inc. - University of Wisconsin–Madison Matritech hopes to be the matriarch of cancer-detection products The biomedical company develops diagnostic tests for different types of cancer Its proprietary nuclear matrix protein (NMP) technology (licensed from MIT) tests blood, cell, and urine samples to detect and monitor differences in healthy cells and cancerous cells; such analyses